Business Description
Medifast Inc
NAICS : 812199
SIC : 7299
Description
Medifast Inc is a US-based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.52 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 0.13 | |||||
| Interest Coverage | 324.7 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 12.03 | |||||
| Beneish M-Score | -1.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 46 | |||||
| 3-Year EBITDA Growth Rate | 45.9 | |||||
| 3-Year EPS without NRI Growth Rate | 44.3 | |||||
| 3-Year FCF Growth Rate | 3.4 | |||||
| 3-Year Book Growth Rate | 23.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.72 | |||||
| 9-Day RSI | 48.03 | |||||
| 14-Day RSI | 47.6 | |||||
| 6-1 Month Momentum % | -34.31 | |||||
| 12-1 Month Momentum % | -41.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.49 | |||||
| Quick Ratio | 0.55 | |||||
| Cash Ratio | 0.45 | |||||
| Days Inventory | 128.76 | |||||
| Days Payable | 56.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.67 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| 3-Year Dividend Growth Rate | 37.4 | |||||
| Forward Dividend Yield % | 5.67 | |||||
| 5-Year Yield-on-Cost % | 32.74 | |||||
| 3-Year Average Share Buyback Ratio | 0.8 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.3 | |||||
| Operating Margin % | 12.14 | |||||
| Net Margin % | 9.22 | |||||
| ROE % | 84.42 | |||||
| ROA % | 40.65 | |||||
| ROIC % | 132.15 | |||||
| ROC (Joel Greenblatt) % | 205.75 | |||||
| ROCE % | 99.07 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.76 | |||||
| PE Ratio without NRI | 8.76 | |||||
| Shiller PE Ratio | 19.68 | |||||
| Price-to-Owner-Earnings | 11.2 | |||||
| PEG Ratio | 0.19 | |||||
| PS Ratio | 0.8 | |||||
| PB Ratio | 8.39 | |||||
| Price-to-Tangible-Book | 8.39 | |||||
| Price-to-Free-Cash-Flow | 11.2 | |||||
| Price-to-Operating-Cash-Flow | 9.62 | |||||
| EV-to-EBIT | 6.11 | |||||
| EV-to-EBITDA | 5.79 | |||||
| EV-to-Revenue | 0.74 | |||||
| EV-to-FCF | 10.12 | |||||
| Price-to-Projected-FCF | 0.96 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.35 | |||||
| Price-to-Graham-Number | 1.81 | |||||
| Price-to-Net-Current-Asset-Value | 23.47 | |||||
| Earnings Yield (Greenblatt) % | 16.37 | |||||
| Forward Rate of Return (Yacktman) % | 27.04 |
